Novel Therapies for Type 2 Diabetes and Obesity Summit
Evvnt Promotion / evvnt
Archiv
30.05.2023 - 01.06.2023Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, 02128 Boston, Massachusetts, USA
Time: 09:00 to 15:30
Kongressthemen The wave of breakthrough therapies in drug-based management of obesity has triggered a renaissance in metabolic disorders. As GLP-1 receptor agonists establish a new gold standard in weight-loss and first-in-class therapies demonstrate additional benefit in type 2 diabetes, stakeholders are flooding in to redefine the metabolic landscape.
Speakers: Ashish Nimgaonkar, Founder and Chief Executive, Glyscend Therapeutics, Jacob Jeppesen, Vice President, Novo Nordisk, Jerry Colca, Chief Scientific Officer, Cirius Therapeutics, and more